Allogene Therapeutics, Inc. (ALLO) Tops Q3 EPS by 3c

Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q3 EPS of ($0.19), $0.03 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.

You May Also Be Interested In

• Take-Two stock drops as GTA 6 leaks continue
• Bessent: we are not in war with Canada - CNBC interview
• Dell Technologies (DELL) call put ratio 1 call to 1.3 puts into quarter results